Clinical and molecular insights into BCG immunotherapy for melanoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and molecular insights into BCG immunotherapy for melanoma
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-03-04
DOI
10.1111/joim.13037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
- (2019) Paolo A. Ascierto et al. Journal of Translational Medicine
- Bacillus Calmette-Guérin strain differences as the basis for immunotherapies against bladder cancer
- (2018) Jun Miyazaki et al. INTERNATIONAL JOURNAL OF UROLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
- (2017) Brock E. Boehm et al. JOURNAL OF UROLOGY
- Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
- (2017) José Mordoh et al. Frontiers in Immunology
- Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
- (2017) Ricardo D. Lardone et al. Frontiers in Immunology
- Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
- (2017) Junbao Yang et al. Frontiers in Oncology
- Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae
- (2016) Mirjam Schenk et al. INFECTION AND IMMUNITY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms
- (2016) Lu Zhang et al. MOLECULAR THERAPY
- Macrophage-mediated inflammatory response decreases mycobacterial survival in mouse MSCs by augmenting NO production
- (2016) Kun Yang et al. Scientific Reports
- Tuberculosis in Newborns: The Lessons of the “Lübeck Disaster” (1929–1933)
- (2016) Gregory J. Fox et al. PLoS Pathogens
- Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
- (2016) Michal Lotem et al. Journal of Immunology Research
- Bacillus Calmette-Guerin Injections for Melanoma Immunotherapy
- (2015) Steven M. Sogge et al. CLINICAL NUCLEAR MEDICINE
- Treatment of In-Transit Melanoma With Intralesional Bacillus Calmette-Guérin (BCG) and Topical Imiquimod 5% Cream
- (2015) Nour Kibbi et al. JOURNAL OF IMMUNOTHERAPY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Nanoparticulation of BCG-CWS for application to bladder cancer therapy
- (2014) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Evidence-based treatment of early-stage melanoma
- (2014) Merrick I. Ross et al. JOURNAL OF SURGICAL ONCOLOGY
- The role of gamma delta T cells in immunity to Mycobacterium bovis infection in cattle
- (2014) Jodi L. McGill et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
- (2014) Kathrin Buffen et al. PLoS Pathogens
- CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions
- (2013) Marta Batus et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells
- (2013) G. Redelman-Sidi et al. CANCER RESEARCH
- Genome Sequencing and Analysis of BCG Vaccine Strains
- (2013) Wen Zhang et al. PLoS One
- Tumor Necrosis Factor-α Signaling in Macrophages
- (2012) Narayanan Parameswaran et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Mycobacterium tuberculosis Rv0652 stimulates production of tumour necrosis factor and monocytes chemoattractant protein-1 in macrophages through the Toll-like receptor 4 pathway
- (2012) Kwangwook Kim et al. IMMUNOLOGY
- Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit Melanoma
- (2012) Travis B. Kidner et al. JOURNAL OF IMMUNOTHERAPY
- NOD2 triggers an interleukin-32–dependent human dendritic cell program in leprosy
- (2012) Mirjam Schenk et al. NATURE MEDICINE
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Re-inventing intratumoral immunotherapy for melanoma
- (2011) Pierre L Triozzi et al. Immunotherapy
- Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006)
- (2011) Dianna E. Saam et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Melanoma survival in the United States, 1992 to 2005
- (2011) Lori A. Pollack et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparable studies of immunostimulating activitiesin vitroamongMycobacterium bovisbacillus Calmette-Guérin (BCG) substrains
- (2009) Daisuke Hayashi et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Dynamic Development of Homing Receptor Expression and Memory Cell Differentiation of Infant CD4+CD25high Regulatory T Cells
- (2009) H. Grindebacke et al. JOURNAL OF IMMUNOLOGY
- Phenotypic differences between BCG vaccines at the proteome level
- (2009) Mauricio Rodríguez-Alvarez et al. TUBERCULOSIS
- The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway
- (2009) Ira Gordon et al. PLOS MEDICINE
- Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall ofMycobacterium bovisbacillus Calmette-Guérin
- (2008) Akira Joraku et al. BJU INTERNATIONAL
- Novel genome polymorphisms in BCG vaccine strains and impact on efficacy
- (2008) Andrea S Leung et al. BMC GENOMICS
- Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999–2006)
- (2008) Nicholas J. Bacon et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now